cilazapril
This page covers all cilazapril drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin-converting enzyme.
Targets
Phase 2 pipeline (1)
- Vascace · Cardiovascular
Cilazapril blocks the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.
Patent intelligence
- cilazapril patent landscape — aggregated cliff calendar, attackable patents, originator estates